CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYR
Lack of sterility assurance
Yes — there is an active recall. 1 ongoing FDA recall mention Heparin (118 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Heparin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Lack of sterility assurance
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.
Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.
Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)
Lack of Assurance of Sterility: Potential leakage of bags.
Lack of Assurance of Sterility: Potential leakage of bags.
Lack of Assurance of Sterility: Potential leakage of bags.
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.